14 Dec 2010: NorDiag has released a live corporate presentation on its website, see below:

The presentation is based upon CEO Mårten Wigstøl's presentation at DnB NOR Markets Health Care Conference, December 1 2010.

Contact:
CEO Mårten Wigstøl                 
Phone. +47 911 65775
            
CFO Tone Kvåle                      
Phone: +47 915 19576

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 37.5 man- labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.

For further information - www.nordiag.com.

Read the notice in Norwegian here